Non-Alcoholic Steatohepatitis: What Can We Learn from Animal Models?

By  

Current Medicinal Chemistry, Vol. 19, Iss. 9, 2012-03 ,pp. : 1389-1404

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabis in the Arm: What Can we Learn from Intravenous Cannabinoid Studies?

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 4906-4914

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary: Fatal French Clinical Trial: What Can We Learn from What Went Wrong?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 7, 2016-08 ,pp. : 752-753

Bentham Science Publishers

Access to resources Recommend Favorite

Today's Challenges in Pharmacovigilance: What can we Learn from Epoetins?

By Ebbers Hans C.  

Drug Safety, Vol. 34, Iss. 4, 2011-04 ,pp. : 273-287

Adis International

Access to resources Recommend Favorite

What can the UK learn from the USA about improving the quality and safety of healthcare?

By Tomson Charles RV   Berwick Donald M  

Clinical Medicine, Vol. 6, Iss. 6, 2006-12 ,pp. : 551-558

Royal College Of Physicians

Access to resources Recommend Favorite